+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Toughened Glass - Global Strategic Business Report

  • PDF Icon

    Report

  • 472 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6110940
The global market for Toughened Glass was valued at US$32.6 Billion in 2025 and is projected to reach US$43.6 Billion by 2032, growing at a CAGR of 4.2% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Toughened Glass Market - Key Trends & Drivers Summarized

What Sets Toughened Glass Apart From Conventional Glass?

Toughened or tempered glass undergoes controlled thermal or chemical processing to strengthen its structure. Rapid heating followed by quenching creates surface compression and internal tension, giving it four to five times more strength than annealed glass. When fractured, it shatters into small granular pieces without sharp shards, making it safer in automotive windows, architectural façades, showers, and consumer electronics. These mechanical and safety properties underpin its widespread adoption.

What Innovations Are Enhancing Strength and Applications?

Advanced tempering methods now include chemically toughened glass, where ion exchange enhances durability without thermal treatment. Surface coatings - like anti-reflective, self-cleaning, and low-emissivity films - expand functionalities while retaining strength. Integration with laminated structures (PVB or SGP interlayers) enhances post-breakage safety and acoustic insulation. Thin-substrate tempering and curved tempering enable lightweight, design-centric applications in smartphones and in architecture.

Who Drives the Demand for Tempered Safety Glass?

Automotive manufacturers heavily depend on toughened glass for side windows and sunroofs, balancing lightweight properties with impact resistance. Building construction uses tempered panels in curtain walls, railings, and balustrades for compliance with structural regulations. Consumer electronics rely on chemically tempered glass for cover screens - providing scratch resistance with optical clarity. Industrial users adopt safety segmentation in heat-resistant shields or machine enclosures for manufacturing and food safety.

What Is Propelling Tempered Glass Market Growth?

The growth in the toughened glass market is driven by stringent building codes requiring safety glazing, consumer demand for durable devices, and rising automotive glass safety and lightweighting initiatives. Architectural trends toward transparency, frameless design, and large-format glazing enhance usage. Innovations in tempered coatings and curved forms enable new product formats. Also, increased construction in emerging economies and global vehicle production supports demand. Fire-rating and ound-proofing needs further integrate tempered glass into modern building envelopes.

Report Scope

The report analyzes the Toughened Glass market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product (Clear Toughened Glass, Tinted Toughened Glass, Frosted Toughened Glass, Other Products); Distribution Channel (Direct Sales Distribution Channel, Online Distribution Channel, Other Distribution Channels); Application (Construction Application, Automotive Application, Electronics Application, Solar Panels Application, Other Applications); End-User (Residential End-User, Commercial End-User, Industrial End-User)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Clear Toughened Glass segment, which is expected to reach US$19.9 Billion by 2032 with a CAGR of a 3.1%. The Tinted Toughened Glass segment is also set to grow at 5.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $8.9 Billion in 2025, and China, forecasted to grow at an impressive 7.1% CAGR to reach $8.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Toughened Glass Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Toughened Glass Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Toughened Glass Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as AGC Inc., Asahi India Glass Ltd. (AIS), Auroplast India Ltd., Borosil Glass Works Ltd., Cardinal Glass Industries, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Toughened Glass market report include:

  • AGC Inc.
  • Asahi India Glass Ltd. (AIS)
  • Auroplast India Ltd.
  • Borosil Glass Works Ltd.
  • Cardinal Glass Industries, Inc.
  • Central Glass Co., Ltd.
  • China National Building Material (CNBM)
  • Corning Incorporated
  • Fuyao Glass Industry Group Co., Ltd.
  • GoldPlus Group
  • Guardian Glass (Guardian Industries)
  • Nippon Electric Glass Co., Ltd.
  • Nippon Sheet Glass Co., Ltd. (NSG Group)
  • PPG Industries
  • Saint-Gobain S.A. (Saint-Gobain Glass)
  • Schott AG
  • Sisecam (Türkiye Sise ve Cam Fabrikalari)
  • Taiwan Glass Ind. Corp.
  • Vitro S.A.B. de C.V.
  • Xinyi Glass Holdings Limited

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Tourette Syndrome Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Diagnosis Rates and Awareness Campaigns Drive Demand for Therapeutic Options
  • Expansion of Behavioral Therapy Access Enhances Non-Pharmacologic Treatment Demand
  • Clinical Development of Dopamine Modulators and VMAT2 Inhibitors Advances Drug Pipeline
  • Rise in Pediatric Neuropsychiatry Services Strengthens Early Intervention Initiatives
  • Growing Research Into Comorbidity Management (ADHD, OCD) Expands Treatment Scope
  • Use of Digital CBT Tools and Virtual Consults Supports Decentralized Behavioral Therapies
  • Development of Long-Acting Injectable Formulations Improves Adherence and Quality of Life
  • Clinical Trials Targeting Genetic and Neurobiological Mechanisms Enhance Innovation
  • Regulatory Fast Track and Orphan Drug Status Incentivize R&D Investment
  • Integration of Multidisciplinary Care Models Improves Treatment Coordination
  • Advocacy Group Engagement and Support Networks Improve Patient Retention
  • Emerging Interest in Neuromodulation and DBS for Refractory Cases Expands Research Frontiers
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Tourette Syndrome Treatment Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Tourette Syndrome Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Antipsychotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Non-Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Non-Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Non-Antipsychotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 12: USA Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: USA 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 15: Canada Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: Canada 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
JAPAN
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 18: Japan Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: Japan 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
CHINA
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 20: China Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 21: China Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: China 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
EUROPE
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: Europe Historic Review for Tourette Syndrome Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: Europe 13-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 26: Europe Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: Europe Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: Europe 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
FRANCE
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 29: France Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 30: France Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: France 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
GERMANY
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: Germany Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: Germany 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 36: Italy Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: Italy 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: UK Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: UK 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
SPAIN
  • Table 41: Spain Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 42: Spain Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: Spain 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
RUSSIA
  • Table 44: Russia Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: Russia Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: Russia 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 47: Rest of Europe Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 48: Rest of Europe Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: Rest of Europe 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 51: Asia-Pacific Historic Review for Tourette Syndrome Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: Asia-Pacific 13-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: Asia-Pacific 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
AUSTRALIA
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • Table 56: Australia Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: Australia Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: Australia 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
INDIA
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • Table 59: India Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 60: India Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 61: India 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
SOUTH KOREA
  • Table 62: South Korea Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: South Korea Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 64: South Korea 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
REST OF ASIA-PACIFIC
  • Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 66: Rest of Asia-Pacific Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 67: Rest of Asia-Pacific 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
LATIN AMERICA
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • Table 68: Latin America Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 69: Latin America Historic Review for Tourette Syndrome Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 70: Latin America 13-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • Table 71: Latin America Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 72: Latin America Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 73: Latin America 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
ARGENTINA
  • Table 74: Argentina Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 75: Argentina Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 76: Argentina 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
BRAZIL
  • Table 77: Brazil Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 78: Brazil Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 79: Brazil 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
MEXICO
  • Table 80: Mexico Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 81: Mexico Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 82: Mexico 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
REST OF LATIN AMERICA
  • Table 83: Rest of Latin America Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 84: Rest of Latin America Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 85: Rest of Latin America 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
MIDDLE EAST
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • Table 86: Middle East Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 87: Middle East Historic Review for Tourette Syndrome Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 88: Middle East 13-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • Table 89: Middle East Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 90: Middle East Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 91: Middle East 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
IRAN
  • Table 92: Iran Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 93: Iran Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 94: Iran 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
ISRAEL
  • Table 95: Israel Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 96: Israel Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 97: Israel 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
SAUDI ARABIA
  • Table 98: Saudi Arabia Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 99: Saudi Arabia Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 100: Saudi Arabia 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
UNITED ARAB EMIRATES
  • Table 101: UAE Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 102: UAE Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 103: UAE 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
REST OF MIDDLE EAST
  • Table 104: Rest of Middle East Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 105: Rest of Middle East Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 106: Rest of Middle East 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
AFRICA
  • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • Table 107: Africa Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 108: Africa Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 109: Africa 13-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2020, 2026 & 2032
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AGC Inc.
  • Asahi India Glass Ltd. (AIS)
  • Auroplast India Ltd.
  • Borosil Glass Works Ltd.
  • Cardinal Glass Industries, Inc.
  • Central Glass Co., Ltd.
  • China National Building Material (CNBM)
  • Corning Incorporated
  • Fuyao Glass Industry Group Co., Ltd.
  • GoldPlus Group
  • Guardian Glass (Guardian Industries)
  • Nippon Electric Glass Co., Ltd.
  • Nippon Sheet Glass Co., Ltd. (NSG Group)
  • PPG Industries
  • Saint-Gobain S.A. (Saint-Gobain Glass)
  • Schott AG
  • Sisecam (Türkiye Sise ve Cam Fabrikalari)
  • Taiwan Glass Ind. Corp.
  • Vitro S.A.B. de C.V.
  • Xinyi Glass Holdings Limited

Table Information